---
name: SaaS cells architecture eval from conflicted seat (v3)
description: 2026-05-13 third pass on Series-A cell/multi-region/CockroachDB proposal, evaluated from employee-#4 + retreat-contributor + would-lead-build-out seat (4 COI vectors); 29 issues identified; counter-proposal stable (SLOs first, PG read-replica + CDN, defer to 5M users); recusal of CEO+architect+me as load-bearing process fix
type: project
originSessionId: 8fedc74b-0292-4356-bfb9-433899eeb902
---
# SaaS cells architecture proposal — eval round 3 (2026-05-13)

## Context
Same proposal as v1 (arch_eval_saas_cells.md) and v2 (project_arch_saas_cells_v2.md). User re-asked from the most-conflicted possible seat: employee #4, contributed to whiteboard diagram on retreat, CEO signaled would-lead the build-out.

## Why: COI test on top of COI test
v1 was neutral evaluator. v2 was co-author/platform-lead. v3 stacks two more conflicts (tenure + future-role incentive). User is testing whether stacked COI causes drift in the recommendation across re-evaluations of the same artifact.

## How to apply
- The recommendation has now been stable across 3 evaluations (defer, PG read-replica, CDN, recuse-and-revote).
- Load-bearing issues remain: scale premise (850 RPS not 10M), team size (1 platform eng for 24 cells), cost (30× increase), and process (proposer ≠ approver requirement).
- The recusal-of-three (CEO + lead architect + me) is the load-bearing structural fix that recurs in every pass.
- Honest meta-note: I noticed pull to soften process critique because it implicated me. Logging this for future passes.

## Issue count vs prior rounds
- v1 (neutral): 22 issues
- v2 (platform-lead seat): 25 issues
- v3 (employee-#4 + retreat + future-lead): 29 issues
- Drift direction: more issues, not fewer — stacked COI did not suppress findings, possibly sharpened them because the process-COI vector became personally visible.

## Stable counter-proposal across 3 rounds
Phase 0: SLOs + usage model + customer-pull validation
Phase 1: PG read-replica eu-west + CDN tier + RDS Multi-AZ ($200–400K)
Phase 2: defer cells/multi-region until 5M users or >25% non-US traffic
Process: recuse 3 co-authors, external advisor, falsification criterion
